Analyst Ratings for Tscan Therapeutics Inc (TCRX)
TCRX Rating Summary
TCRX Price Target Summary
- Highest: $7.00 (H.C. Wainwright)
- Lowest: $7.00 (H.C. Wainwright)
- Average: $7.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.00 (+660.9%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
Avg. $ Target:
$7.00 (+660.9%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/14/2025 | Morgan Stanley | Maxwell Skor | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
1.19 (0.92) |
-22.69% | Details |
| 11/4/2025 | BTIG » Updated 12/9/2025 |
Justin Zelin | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.24 (0.92) |
-25.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
